Stem Cell & Cord Blood Transport: Why Specialist
Couriers Are Essential for These Life-Saving Materials

What Are Stem Cells and Why Do They Need Specialist Transport?

Stem cells are the precursor cells that give rise to all the specialised tissues and organs of the human body. Unlike heart muscle cells or hepatocytes, stem cells can still divide and differentiate — producing copies of themselves and transforming into more specialised cell types in response to signals from the body.

In medicine, this capacity is being put to remarkable use. Haematopoietic stem cells are used in transplants to reconstitute the immune systems of patients with leukaemia, lymphoma and other blood cancers. Cord blood stem cells, banked at birth, are a source of perfectly matched material that could be used if a child later develops a condition treatable by transplantation. Advanced cell therapy products — CAR-T cells, gene-modified HSCs — are among the most innovative treatments in development anywhere in oncology and immunology today.

And that biological value is exactly what makes stem cells so demanding to transport. A vial of haematopoietic stem cells may be the only available HLA match for a patient in urgent need. A cord blood unit stored at a private bank represents years of premium payments and the expectation that it will be there when needed. A fresh bone marrow harvest must reach the transplant centre within a time window measured in hours. In every one of these scenarios, a transport failure — a temperature breach, a documentation error, a delay that pushes a product past its window — can have direct clinical consequences for a patient who is counting on that product to work.

Types of Stem Cells: HSCs, MSCs, Cord Blood and Bone Marrow

"Stem cells" covers a family of different cell types with different biological properties, different clinical uses, and different transport requirements. Here's a practical overview of the main types we handle.

Haematopoietic Stem Cells (HSCs)

HSCs are the blood-forming stem cells found in bone marrow and circulating peripheral blood. They produce all blood cell types — red cells, white cells, platelets — and HSC transplantation is the primary curative treatment for many blood cancers (leukaemia, lymphoma, myeloma) and certain non-malignant conditions including aplastic anaemia and inherited immune deficiencies.

HSCs can be cryopreserved and stored long-term, or used fresh within a narrow window. Frozen HSCs travel in cryogenic dry shippers at −196°C. Fresh HSC products collected by apheresis must travel at +2–8°C and be used within 24 to 72 hours of collection, depending on the product and the clinical protocol. The timing pressure on fresh HSC transport is significant — the clock starts running at the end of the apheresis collection.

Mesenchymal Stem Cells (MSCs)

MSCs are found in bone marrow, adipose tissue, umbilical cord tissue and other sources. They differentiate into bone, cartilage, fat and connective tissue cell types, and they're increasingly used in regenerative medicine — from cartilage repair to managing graft-versus-host disease after transplant.

Fresh MSC products are time-sensitive and temperature-sensitive, requiring transport at +2–8°C in validated containers and use within a specified window. Cryopreserved MSC products travel at −196°C, handled the same as any other cryogenic biological material.

Cord Blood Stem Cells

Cord blood is collected from the umbilical cord and placenta immediately after birth. It's been used in transplantation since the late 1980s and has a significant advantage over bone marrow: cord blood stem cells are more tolerant of HLA mismatches, meaning a unit can be used even when the donor-recipient match isn't perfect. For patients in ethnic minority groups where matched unrelated donors can be hard to find, cord blood units often represent a viable alternative.

Cord blood is cryopreserved and stored at −196°C — either in public banks (available to any matched patient) or private family banks (reserved for the family's own use). When a unit is needed for transplantation, it travels from the bank to the transplant centre under cryogenic conditions, often against a tight clinical timeline.

Bone Marrow Harvests

Traditional bone marrow — aspirated from the posterior iliac crest of a donor under general anaesthesia — is a fresh product with a short window. It travels at controlled temperature and must reach the transplant centre within 24 hours of harvest. Bone marrow harvest transport is among the most time-critical work we do. It requires a team that is genuinely available 24/7 with no exceptions, because the collection schedule is set by the clinical team, not by the courier's operational preferences.

Why Cord Blood Banking Is Growing — And What It Means for Transport

Cord blood banking has grown significantly over the past two decades. Both public banking (through the NHS Cord Blood Bank within the Anthony Nolan network) and private family banking have expanded, with more families choosing to bank at birth as a form of biological insurance.

The case for private banking: if a child or close family member later develops a condition treatable by stem cell transplantation, a stored, perfectly HLA-matched cord blood unit could be invaluable. The counter-argument is that the probability of any given child needing their own stored cord blood is low, and public donation benefits more patients. Both perspectives have merit. For families with a known genetic risk of a relevant condition, or those from ethnic backgrounds where public bank matches are statistically harder to find, private banking is a reasonable decision.

For us as a courier, the practical implication is straightforward: more cord blood banking means more transport requests — both for inter-facility transfers and for units being released for transplantation. The two types have different time pressures and logistics requirements, and both need handling by a specialist service that understands what's at stake.

Temperature Requirements: Why −196°C Is Non-Negotiable

The temperature requirement for cryopreserved stem cells is −196°C — the temperature of liquid nitrogen. This isn't a conservative specification with margin to play with. It's the temperature at which the cryoprotected cells are in a stable, inert state. At any significantly warmer temperature, problems begin.

The thermodynamics: when cells are vitrified or slow-frozen with cryoprotectants, the water inside and around them is converted into an amorphous solid rather than crystalline ice. This glassy state is thermodynamically unstable — it's only maintained by the extremely low temperature. As temperature rises above approximately −130°C (the glass transition temperature for most cryoprotected systems), the probability of devitrification — ice crystal formation — rises sharply.

Ice crystal formation inside a stem cell is destructive. Growing crystals puncture membranes, disrupt organelles, and compromise the cell's ability to engraft and divide after transplantation. A product that has undergone even partial devitrification may look completely normal — the vials are intact, the contents unremarkable — but the biological quality of the cells is irreversibly damaged. The patient receives a product that doesn't engraft. With some of these products, there may not be a second chance.

Why ANY Temperature Deviation Is Catastrophic

With some pharmaceutical products, a brief temperature excursion can be assessed and a risk-based decision made about whether to use the product. Cryopreserved stem cells don't work that way. There is no reliable test that confirms, after the fact, that a temperature excursion hasn't caused functional damage. A cell viability assay — which measures the proportion of live cells — may look normal even after a damaging excursion, because the damage affects engraftment capacity and differentiation potential, not simple viability. A dead cell looks dead. A functionally compromised cell looks exactly like a healthy one until it fails to engraft in the patient.

This means any confirmed or suspected temperature deviation during transport is grounds for serious concern and potential rejection of the product. For a family whose child's cord blood unit was compromised in transit, or for a transplant recipient whose only available matched HSC was damaged by a temperature breach, there's no adequate remedy. The unit may be irreplaceable. The transplant may not be possible.

That's the weight this work carries. It's why we apply the most rigorous standards to equipment validation, pre-transport preparation, courier training, and contingency planning for every stem cell transport we undertake — regardless of how straightforward the logistics appear on the surface.

Who Uses Stem Cell and Cord Blood Transport Services?

Stem cell transport services are needed by a range of organisations, each with different requirements and different time pressures:

• NHS and private transplant centres: Hospitals performing bone marrow and stem cell transplants need reliable courier services for incoming donor products — whether HSC apheresis products, bone marrow harvests or cord blood units.
• Cord blood banks: Both public and private cord blood banks require transport services for units being released for transplantation, for inter-bank transfers, and for incoming cord blood collections.
• Cancer patients and their families: Patients undergoing high-dose chemotherapy with autologous stem cell rescue need their own previously collected stem cells returned at precisely the right time.
• Patients with rare diseases: Conditions such as sickle cell disease, thalassaemia, and rare inherited immune deficiencies may be treated with allogeneic HSC transplantation. These patients — often children — may depend on a matched unit being sourced internationally and transported under perfect conditions.
• Cell therapy developers: Biotech and pharma companies developing cell therapies (including CAR-T cell products and other advanced therapy medicinal products) require specialist transport for their investigational and commercial products.
• International transplant registries: Organisations such as Anthony Nolan, DKMS and the World Marrow Donor Association coordinate the international shipment of bone marrow and stem cell products between donors in one country and recipients in another.

Regulatory Framework for Stem Cell Transport

Stem cell transport sits within a layered regulatory framework that varies depending on product type and whether the transport is domestic, intra-EU, or international.

In the UK

The MHRA regulates advanced therapy medicinal products, including cell therapy products. The UK Blood Safety and Quality Regulations 2005 govern the collection, testing, processing, storage and distribution of blood components including peripheral blood and bone marrow HSC products. NHSBT coordinates HSC transplantation services within the NHS and sets standards for the handling and transport of HSC products in NHS transplant programmes.

Private cord blood banks are licensed by the Human Tissue Authority (HTA), the independent regulator for tissue establishments in England, Wales and Northern Ireland. The HTA requires cord blood banks to operate to standards that include appropriate transport procedures for collected and stored units. Couriers working with HTA-licensed banks need to understand and work within these requirements.

In the EU

EU cell therapy products fall under the Advanced Therapy Medicinal Products Regulation (EC 1394/2007) and relevant GMP guidelines. The EU Tissues and Cells Directive (2004/23/EC) governs import and export of human tissues and cells between EU member states and third countries — including the UK post-Brexit. International stem cell transport for transplantation purposes is also subject to FACT and JACIE standards, which are the leading accreditation frameworks for haematopoietic transplant programmes internationally. Many transplant centres will only accept products transported in compliance with these standards.

IATA Dangerous Goods Regulations

Air transport of cryopreserved stem cells falls under IATA Dangerous Goods Regulations. Category B biological substances must be packaged to Packing Instruction P650. Fresh stem cell products transported in dry ice (solid CO2) are subject to additional IATA requirements covering dry ice as a dangerous good in its own right. Our couriers hold current IATA dangerous goods training and we prepare full IATA-compliant documentation for every air transport.

Chain of Custody for Stem Cell Products

The chain of custody for stem cell and cord blood transport is, if anything, even more critical than for other biological materials, because the stakes are so high and the products so precious. Our chain of custody protocol for stem cell transport includes:

• Pre-transport verification: Before collection, we confirm the product identification, the receiving transplant centre's details, the expected transport time, and any time-critical requirements (particularly for fresh products).
• Dual identification at collection: The releasing scientist or clinician and our courier independently verify the product identification against the transport documentation. Both sign the manifest.
• Sealed transport vessel: The dry shipper or temperature-controlled container is sealed at source and is not opened until delivery at the transplant centre.
• Continuous monitoring where required: For high-value or time-critical transports, electronic temperature logging provides a continuous record that accompanies the product to the receiving centre.
• On-call communication: Our operations team is reachable 24/7 for stem cell transports. Any incident, delay or concern is escalated immediately, with direct communication to the transplant centre's clinical team if required.
• Dual identification at delivery: The receiving transplant centre scientist and our courier independently verify the product identification on receipt. The delivery receipt is signed and copies retained by both parties.

How Stem Cell Transport Works in Practice

The practical process varies significantly depending on the product type and urgency. Here are three common scenarios:

Cryopreserved Cord Blood Unit: Bank to Transplant Centre

When a transplant centre identifies a matched cord blood unit and requests its release, the bank transfers the unit from storage into a transport dry shipper. We collect the vessel, complete the identity verification, and transport it to the transplant centre by the most appropriate route — road for shorter UK distances, air for longer or international transfers. From bank release to transplant centre receipt: typically within 24 hours for UK domestic transfers, 24 to 48 hours for European transfers.

Fresh HSC Apheresis Product: Donor to Recipient

When an unrelated donor has been mobilised and their stem cells collected by apheresis, the clock starts at the end of the collection. The product needs to reach the transplant centre quickly — ideally within 24 hours, and as fast as the logistics allow. Our courier meets the collection team, takes custody of the product in a validated +2–8°C container, and goes directly to the departure point. No intermediate stops. The transplant centre team gets a real-time ETA and is ready to receive on arrival. For cross-country or international transfers, this means a flight is often pre-booked before the collection even starts.

Autologous Stem Cell Product: Storage Facility to Treatment Centre

Patients undergoing high-dose chemotherapy with autologous stem cell rescue have their own cells collected and stored before conditioning begins. When the conditioning is complete, the cells must come back within a specific therapeutic window — delay means the patient is without immune function for longer than clinically acceptable. We coordinate with the storage facility and the transplant centre to get the timing exactly right. This is one of those transports where the clinical team genuinely depends on us to execute precisely.

International Stem Cell Transport

International stem cell transport is a regular part of our work. The UK is connected to international bone marrow registries through Anthony Nolan and the WMDA, and we handle matched HSC products moving between UK transplant centres and donors or banks in Europe, North America, and occasionally further afield.

One thing worth flagging upfront: since Brexit, importing cord blood and HSC products into the UK requires explicit import authorisation from the relevant UK competent authority — HTA for tissue-based products, MHRA for ATMPs. This is not optional paperwork. If a transplant centre contacts us close to the collection date without having started the regulatory process, we can sometimes help expedite, but we'd much rather that paperwork begin as soon as the product source is confirmed. Don't contact us two days before a collection hoping the import documentation will sort itself out.

For international fresh stem cell transports — bone marrow or apheresis products crossing a border — timing is everything. We plan with the tightest possible margins. Direct flights where they exist. Pre-booked seats and courier slots. A documented contingency route in case of disruption. Our couriers travel with a full pre-prepared documentation pack for every international transport: IATA shipper's declaration, import/export permits, chain of custody records, dry shipper validation certificates. Customs delays kill fresh products. We work hard to make sure they don't happen.

Choosing a Specialist Courier for Stem Cells and Cord Blood

Not every courier who describes themselves as a "specialist biological transport service" has the training or equipment for stem cell products. This is an area where it's worth asking specific questions and expecting specific answers. If a courier can't tell you the validated hold time of their dry shippers off the top of their head, that's informative.

Here's what we'd suggest you ask any prospective courier:

• What dry shippers do you use, and what is their validated hold time? You want a specific vessel model and a validated performance figure, not a general answer about "cryogenic containers."
• Do you provide continuous temperature monitoring on every stem cell transport? A temperature log accompanying the product to the receiving centre matters — not just for this transport, but for your own documentation obligations.
• Are you genuinely available 24/7? Ask what happens if a collection finishes at 2am on a Sunday. If the answer involves on-call systems and response windows, push further.
• Can you handle fresh products with a 24-hour window? The courier needs to be ready to move immediately from the moment collection is confirmed.
• Do you have experience with FACT/JACIE-compliant transport? Many transplant programmes will only accept products transported in line with these standards. Know whether your courier does.
• Can you provide references from transplant centres or cord blood banks? A credible courier has these readily available. Hesitation here is a red flag.

We're happy to answer all of these directly and in writing. ISO 9001 certification, dry shipper validation certificates, IATA training records — we provide all of this to new clients as standard, without being asked twice.

Cost Considerations for Stem Cell Transport

Stem cell transport is specialist work and the cost reflects that. We're not going to pretend otherwise. Validated dry shippers, genuine 24/7 availability, IATA-trained couriers, full documentation — these are real operational costs, and any provider quoting very low prices for this type of work should prompt the question of what's being cut.

For transplant centres and cord blood banks, the relevant comparison isn't specialist vs. general courier pricing. It's specialist courier cost vs. the cost of a compromised transplant. An irreplaceable HSC product that's temperature-breached in transit, or a cord blood unit rendered unusable by a documentation failure, is a clinical and institutional problem of a completely different magnitude from a courier invoice. The maths isn't complicated.

For families moving privately banked cord blood units — perhaps to a new bank, or releasing a unit for treatment — we provide transparent, itemised quotes. No surprises. Contact us with the details of your transport and we'll give you a clear figure.

Frequently Asked Questions About Stem Cell Transport

Can you transport bone marrow on a bank holiday or over a weekend?

Yes, without exception. Fresh bone marrow collections happen when the donor's clinical schedule dictates — not when it's convenient for the courier. If that means collection at 6pm on Easter Sunday and a same-night flight to a European transplant centre, that's what happens. We're set up for it. We don't charge a surcharge for unsociable hours on urgent clinical transports — that's just the nature of the work.

What happens if there's a flight delay during an international fresh stem cell transport?

This is why we plan contingency routes before every transport, not after a problem develops. For fresh HSC products, we identify alternative routing — different carrier, different hub, ground transfer option — at the planning stage, so if the booked flight is delayed or cancelled, we're already moving to the contingency rather than starting to think about one. The transplant centre's clinical team is kept informed throughout. For cryopreserved products, the dry shipper's hold time gives us a buffer and we rebook the next viable service immediately.

We're a transplant centre thinking about switching couriers. How do we start that conversation?

Contact us via WhatsApp or email — details at the bottom of this page. We'll want to understand your typical product types, routes, and volumes. In return, we'll give you our full documentation set: ISO 9001 certificate, dry shipper validation data, IATA dangerous goods training records, and references from transplant centres we currently work with. Switching courier is a significant operational decision — we're happy to answer every question before you commit to anything.